Evidence map›Paper›PMID 31048434›Full record

Observational studyBMJ open2019

Diabetes & Women's Health (DWH) Study: an observational study of long-term health consequences of gestational diabetes, their determinants and underlying mechanisms in the USA and Denmark.

Cuilin Zhang, Sjurdur F Olsen, Stefanie N Hinkle, Robert E Gore-Langton, Allan Vaag, Louise Groth Grunnet, Edwina H Yeung, Wei Bao, Katherine Bowers, Aiyi Liu and 8 more

Abstract readObservational Study
In one paragraph

Observational study in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Cuilin ZhangEpidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
Sjurdur F OlsenCentre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Stefanie N HinkleEpidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.ORCID 0000-0003-4312-708X
Robert E Gore-LangtonEmmes Corporation, Rockville, Maryland, USA.
Allan VaagCardiovascular and Metabolic Disease (CVMD)Translational Medicine Unit, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Mölndal, Sweden.
Louise Groth GrunnetDepartment of Endocrinology, Diabetes and Bone-metabolicResearch Unit, Rigshospitalet, Copenhagen, Denmark.
Edwina H YeungEpidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
Wei BaoDepartment of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
Katherine BowersDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Aiyi LiuBiostatistics and Bioinformatics Branch, Division of Intramural Population Health Research, Eunice KennedyShriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
James L MillsEpidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
Seth ShermanEmmes Corporation, Rockville, Maryland, USA.
Audrey J GaskinsHarvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Sylvia H LeyHarvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Camilla M MadsenDepartment of Endocrinology, Diabetes and Bone-metabolicResearch Unit, Rigshospitalet, Copenhagen, Denmark.
Jorge E ChavarroHarvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Frank B HuHarvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Diabetes & Women’s Health Study team

Funding

Life Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7M
NCI NIH HHS UM1 CA176726NICHD NIH HHS HHSN275201100002CNICHD NIH HHS HHSN275201100002GNICHD NIH HHS HHSN275201300026INICHD NIH HHS HHSN275201500003C
6 · The paper itself

Abstract

purposeWomen who experience gestational diabetes mellitus (GDM) are at exceptionally high-risk of developing type 2 diabetes (T2DM) later in life. However, limited information is available about genetic and environmental factors that are implicated in the progression from GDM to T2DM.

participantsThe Diabetes & Women's Health (DWH) Study applied a hybrid design, which combined new prospective data collection with existing data in two prospective cohorts, the Danish National Birth Cohort (DNBC) and the Nurses' Health Study II (NHS II). In total, the DWH Study identified 7759 women with a GDM diagnosis from both cohorts; 4457 women participated in the DWH Study data collection, which included two cycles of follow-up from 2012 to 2014 and 2014 to 2016. FINDINGS TO DATE: Progression from GDM to T2DM was high. In the NHS II group, by 2013, 23.1% (n=846/3667) developed T2DM. In the DNBC group, at cycle 1 (2012-2014), the progression rate was even higher: 27.2% (n=215/790) had developed T2DM. Furthermore, we have shown that women who had GDM experienced a significantly greater risk of hypertension and cardiovascular diseases, as well as early stages of glomerular hyperfiltration and renal damage. Moreover, the DWH Study findings have shown that healthful diet and lifestyle factors and weight control were related to a lower risk of T2DM, hypertension and cardiovascular diseases. FUTURE PLANS: Primary data collection for the DWH Study is complete and investigators are currently investigating interactions of the abovementioned modifiable factors with T2DM genetic susceptibility in determining the risk of progression from GDM to T2DM. Findings from ongoing work will provide further insights for identifying more precise prevention strategies for T2DM and comorbidities in this high-risk population. Future work will examine novel biomarkers of health and disease in this cohort.

Indexed as

AdultCardiovascular DiseasesComorbidityDenmarkDiabetes, GestationalDiabetes Mellitus, Type 2Disease ProgressionFemaleHumansHypertensionLife StylePregnancyProspective StudiesRisk FactorsUnited StatesYoung Adultdiabetes in pregnancyepidemiologygestational diabetespublic health

Identifiers

PMID31048434
PMCPMC6502016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.